1. Luo, Jiefeng, Chen, Liechun, Huang, Xiaohua, Mo, Jingjia, Zou, Donghua. 2022. REPS1 as a Potential Biomarker in Alzheimer's Disease and Vascular Dementia. In Frontiers in aging neuroscience, 14, 894824. doi:10.3389/fnagi.2022.894824. https://pubmed.ncbi.nlm.nih.gov/35813961/
2. Xu, J, Zhou, Z, Zeng, L, Xie, Y, Mao, Y. . Cloning, expression and characterization of a novel human REPS1 gene. In Biochimica et biophysica acta, 1522, 118-21. doi:. https://pubmed.ncbi.nlm.nih.gov/11750063/
3. Wydrych, Agata, Pakuła, Barbara, Jakubek-Olszewska, Patrycja, Lebiedzińska-Arciszewska, Magdalena, Wieckowski, Mariusz R. 2024. Metabolic alterations in fibroblasts of patients presenting with the MPAN subtype of neurodegeneration with brain iron accumulation (NBIA). In Biochimica et biophysica acta. Molecular basis of disease, 1871, 167541. doi:10.1016/j.bbadis.2024.167541. https://pubmed.ncbi.nlm.nih.gov/39419454/
4. Kolarova, Hana, Tan, Jing, Strom, Tim M, Wagner, Matias, Klopstock, Thomas. 2022. Lifetime risk of autosomal recessive neurodegeneration with brain iron accumulation (NBIA) disorders calculated from genetic databases. In EBioMedicine, 77, 103869. doi:10.1016/j.ebiom.2022.103869. https://pubmed.ncbi.nlm.nih.gov/35180557/
5. Dergai, Oleksandr, Novokhatska, Olga, Dergai, Mykola, Moreau, Jacques, Rynditch, Alla. 2010. Intersectin 1 forms complexes with SGIP1 and Reps1 in clathrin-coated pits. In Biochemical and biophysical research communications, 402, 408-13. doi:10.1016/j.bbrc.2010.10.045. https://pubmed.ncbi.nlm.nih.gov/20946875/
6. Boissel, Laurent, Fillatre, Jonathan, Moreau, Jacques. 2012. Identification and characterization of the RLIP/RALBP1 interacting protein Xreps1 in Xenopus laevis early development. In PloS one, 7, e33193. doi:10.1371/journal.pone.0033193. https://pubmed.ncbi.nlm.nih.gov/22413001/
7. Kim, Jae Sik, Lee, Joo Ho, Jeon, Sang-Rok, Jeon, Seung Hyuck, Wu, Hong-Gyun. 2023. Identification of Genes Involved in EGF-induced Apoptosis Using CRISPR/Cas9 Knockout Screening: Implications for Novel Therapeutic Targets in EGFR-Overexpressing Cancers. In Cancer research and treatment, 55, 737-745. doi:10.4143/crt.2022.1414. https://pubmed.ncbi.nlm.nih.gov/36596724/